About
Profile
Our corporate responsibility approach is aligned with our company’s focus on invention, and underscores our commitment to overcoming the greatest obstacles to health and well-being, developing and rewarding our employees, protecting the environment, and
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
MRK
The pharmaceutical giant announced Tuesday that the European Commission has approved a combination of drugs including Mercks Keytruda as a treatment for bladder cancer. Shares of Merck were little changed.
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- Merck trades higher as Keytruda, Gardasil drive Q1 growth amid COVID pill decline
- Merck Non-GAAP EPS of $1.40 beats by $0.03, revenue of $14.48B beats by $660M
- Democratic senators introduce bill to enhance CMS drug price negotiations
- Pfizer, BioNTech hit new 52-week lows
- Merck, AstraZeneca dip as FDA reviews cancer drug ahead of AdCom meeting
- Will the Keytruda wave buoy Merck's Q1 results once again?
- EU publishes proposed reforms for pharma industry
- Bipartisan agreement reached in Senate prescription drug price legislation
- What is behind biotech M&A resurgence?
- Catalyst watch: Earnings blitz, Mobileye lockup expiration and the new one-day VIX debut
- Earnings Week Ahead: Amazon, Meta Platforms, Alphabet, Coca-Cola, Boeing, and more
- Prometheus soars 70%, Merck dips after ~$11B buyout deal
- Prometheus Biosciences had other bidders besides Merck - report
- Moderna, Merck post detailed Phase 2 data for mRNA cancer shot in melanoma
- Merck inks ~$11B all-cash deal to acquire Prometheus
- Merck said to be close to acquiring Prometheus Biosciences - WSJ
- Ghana 1st in world to approve new malaria vaccine by Oxford
- Hot Stocks: PGR drops on earnings; CNSL rises on buyout offer; MRK higher on analyst upgrade; EDIT gains; HOG slides
- Merck upgraded at Citi despite Keytruda patent cliff
- Merck's Keytruda combo gets FDA review for initial therapy in gastric, esophagus cancer
Earnings History
| Date | EPS / Forecast | Revenue / Forecast | |
|---|---|---|---|
| February 3, 2022 | 1.8 / 1.52 | 13.52B / 13.14B |
Beat! |
| October 28, 2021 | 1.75 / 1.55 | 13.15B / 12.32B |
Beat! |
| July 29, 2021 | 1.31 / 1.31 | 11.4B / 11.08B |
Beat! |
| April 29, 2021 | 1.33 / 1.53 | 12.08B / 12.61B | |
| February 4, 2021 | 1.32 / 1.38 | 12.51B / 12.67B | |
| October 27, 2020 | 1.74 / 1.44 | 12.55B / 12.21B |
Beat! |
| July 31, 2020 | 1.37 / 1.06 | 10.87B / 10.4B |
Beat! |
| April 28, 2020 | 1.5 / 1.34 | 12.06B / 11.48B |
Beat! |
| February 5, 2020 | 1.16 / 1.15 | 11.87B / 11.98B | |
| October 29, 2019 | 1.51 / 1.24 | 12.4B / 11.64B |
Beat! |
| July 30, 2019 | 1.3 / 1.16 | 11.76B / 10.96B |
Beat! |
| April 30, 2019 | 1.22 / 1.05 | 10.82B / 10.47B |
Beat! |
| February 1, 2019 | 1.04 / 1.04 | 11B / 10.94B |
Beat! |
| October 25, 2018 | 1.19 / 1.14 | 10.79B / 10.89B | |
| July 27, 2018 | 1.06 / 1.03 | 10.47B / 10.28B |
Beat! |
| May 1, 2018 | 1.05 / 1 | 10.04B / 10.09B | |
| February 2, 2018 | 0.98 / 0.94 | 10.43B / 10,494M | |
| October 27, 2017 | 1.11 / 1.03 | 10.33B / 10,545M | |
| July 28, 2017 | 1.01 / 0.87 | 9.93B / 9,746M |
Beat! |
| May 2, 2017 | 0.88 / 0.83 | 9.43B / 9,250M |
Beat! |
| Date | Price | Open | High | Low | Vol | Change | ER | |||
|---|---|---|---|---|---|---|---|---|---|---|
| May 26, 2023 | 111.07 | 112 |
113.19
|
110.65
|
6.3M | -1.1% | ||||
| May 25, 2023 | 112.3 | 113.5 |
113.5
|
111.09
|
6.7M | -1.14% | ||||
| May 24, 2023 | 113.6 | 114.11 |
114.32
|
112.55
|
4.5M | 0.29% | ||||
| May 23, 2023 | 113.27 | 113.97 |
114.79
|
113.05
|
7.6M | -1.07% | ||||
| May 22, 2023 | 114.49 | 115.48 |
117.08
|
114.33
|
5.6M | -0.87% | ||||
| May 19, 2023 | 115.49 | 114.33 |
116.24
|
114.1
|
7.6M | 1.31% | ||||
| May 18, 2023 | 114 | 114.14 |
115.07
|
113.33
|
6.4M | -0.66% | ||||
| May 17, 2023 | 114.76 | 116.37 |
116.65
|
113.48
|
7.2M | -1.14% | ||||
| May 16, 2023 | 116.08 | 115.88 |
116.76
|
115.29
|
4.3M | -0.25% | ||||
| May 15, 2023 | 116.37 | 117.14 |
117.74
|
115.49
|
5.7M | -0.66% | ||||
| May 12, 2023 | 117.14 | 118 |
118.55
|
116.69
|
5.2M | -0.35% | ||||
| May 11, 2023 | 117.55 | 117.58 |
117.79
|
116.38
|
5.6M | -0.3% | ||||
| May 10, 2023 | 117.9 | 117.41 |
118.17
|
116.42
|
5.6M | 0.40% | ||||
| May 9, 2023 | 117.43 | 118.25 |
118.63
|
117.34
|
4.9M | -0.8% | ||||
| May 8, 2023 | 118.38 | 117.08 |
118.44
|
116.44
|
5.2M | 0.59% | ||||
| May 5, 2023 | 117.68 | 117.38 |
117.89
|
116.56
|
4.5M | 0.26% | ||||
| May 4, 2023 | 117.37 | 118 |
118
|
116.49
|
6.5M | -0.72% | ||||
| May 3, 2023 | 118.22 | 118.35 |
119.65
|
117.93
|
6.7M | 0.28% | ||||
| May 2, 2023 | 117.89 | 116.67 |
118.39
|
115.81
|
8.2M | 1.33% | ||||
| May 1, 2023 | 116.34 | 115.8 |
116.6
|
115.27
|
5.2M | 0.75% | ||||
| Apr 28, 2023 | 115.47 | 114.36 |
115.53
|
113.46
|
8.1M | 0.27% | ||||
| Apr 27, 2023 | 115.16 | 114.6 |
115.36
|
110.65
|
10.0M | 1.53% | ||||
| Apr 26, 2023 | 113.43 | 115.2 |
115.2
|
112.72
|
6.6M | -2.66% | ||||
| Apr 25, 2023 | 116.53 | 116.21 |
116.86
|
115.91
|
5.7M | 0.51% | ||||
| Apr 24, 2023 | 115.94 | 115.64 |
116.28
|
114.77
|
4.3M | 0.49% | ||||
| Apr 21, 2023 | 115.37 | 114.87 |
115.65
|
114.59
|
6.6M | 1.05% | ||||
| Apr 20, 2023 | 114.17 | 114.18 |
114.52
|
113
|
4.7M | 0.04% | ||||
| Apr 19, 2023 | 114.13 | 114.49 |
115.39
|
114.01
|
4.7M | -0.61% | ||||
| Apr 18, 2023 | 114.83 | 114.48 |
115.12
|
113.73
|
5.5M | -0.16% | ||||
| Apr 17, 2023 | 115.01 | 115.69 |
116.44
|
114.2
|
6.6M | -0.26% | ||||
| Apr 14, 2023 | 115.31 | 115.74 |
116.17
|
114.66
|
5.0M | -0.23% | ||||
| Apr 13, 2023 | 115.58 | 114.97 |
115.82
|
113.65
|
7.3M | 1.61% | ||||
| Apr 12, 2023 | 113.75 | 112.25 |
114.31
|
111.88
|
6.1M | 1.12% | ||||
| Apr 11, 2023 | 112.49 | 112.72 |
113.31
|
112.32
|
5.6M | -0.11% | ||||
| Apr 10, 2023 | 112.61 | 112.96 |
113.09
|
111.17
|
6.4M | 0.25% | ||||
| Apr 6, 2023 | 112.33 | 113 |
114.17
|
111.64
|
6.9M | 0.38% | ||||
| Apr 5, 2023 | 111.91 | 109.91 |
112.34
|
109.58
|
8.0M | 2.83% | ||||
| Apr 4, 2023 | 108.83 | 108.7 |
109.34
|
108.15
|
6.1M | -0.04% | ||||
| Apr 3, 2023 | 108.87 | 105.95 |
109.48
|
105.57
|
7.0M | 2.33% | ||||
| Mar 31, 2023 | 106.39 | 106.23 |
106.53
|
105.52
|
7.2M | 0.44% | ||||
| Mar 30, 2023 | 105.92 | 105.12 |
106.2
|
104.54
|
5.0M | 0.95% | ||||
| Mar 29, 2023 | 104.92 | 105.62 |
105.87
|
104.53
|
6.3M | -0.58% | ||||
| Mar 28, 2023 | 105.53 | 106.61 |
107.03
|
105.43
|
6.7M | -1.31% | ||||
| Mar 27, 2023 | 106.93 | 106.08 |
107.61
|
105.99
|
7.6M | 2.03% | ||||
| Mar 24, 2023 | 104.8 | 104.09 |
105.01
|
102.44
|
6.7M | 0.55% | ||||
| Mar 23, 2023 | 104.23 | 104.1 |
104.63
|
103.46
|
6.8M | -0.16% | ||||
| Mar 22, 2023 | 104.4 | 105.47 |
106
|
104.39
|
5.7M | -1.08% | ||||
| Mar 21, 2023 | 105.54 | 106 |
106.43
|
104.76
|
11.6M | -0.29% | ||||
| Mar 20, 2023 | 105.85 | 104.82 |
106.91
|
104.82
|
12.9M | 1.68% | ||||
| Mar 17, 2023 | 104.1 | 107.15 |
107.31
|
103.49
|
26.4M | -3.02% | ||||
| Mar 16, 2023 | 107.34 | 106.5 |
107.71
|
104.22
|
9.4M | -0.27% | ||||
| Mar 15, 2023 | 107.63 | 106.48 |
108.03
|
105.57
|
10.9M | 0.62% | ||||
| Mar 14, 2023 | 106.97 | 105.45 |
107.13
|
104.52
|
9.8M | 1.17% | ||||
| Mar 13, 2023 | 105.73 | 104.47 |
108.84
|
104.4
|
10.7M | -1.82% | ||||
| Mar 10, 2023 | 107.69 | 107.44 |
110.72
|
107.34
|
9.7M | 0.08% | ||||
| Mar 9, 2023 | 107.6 | 109.3 |
109.9
|
107.11
|
5.8M | -0.63% | ||||
| Mar 8, 2023 | 108.28 | 110.93 |
111.28
|
107.59
|
8.4M | -2.69% | ||||
| Mar 7, 2023 | 111.27 | 111.77 |
112.18
|
110.71
|
13.8M | 0.15% | ||||
| Mar 6, 2023 | 111.1 | 107.66 |
111.24
|
107.45
|
17.8M | 3.95% | ||||
| Mar 3, 2023 | 106.88 | 107.38 |
107.39
|
106.13
|
6.1M | 0% | ||||